Nervora supports nerve health through a multi-nutrient approach: antioxidant protection, nerve energy metabolism, and myelin maintenance. Here is each mechanism in plain language.
Nervora works by supplying nutrients that protect and nourish nerve cells. Alpha-lipoic acid fights oxidative stress and supports circulation; benfotiamine supports nerve energy and guards against glucose-related stress; and vitamin B12 maintains the myelin sheath and healthy signaling. Together they support nerve function from several angles.
Healthy nerves need three things: protection from oxidative stress, a steady energy supply, and intact insulation (the myelin sheath). When those break down - through aging, nutrient gaps, or elevated blood sugar - nerve signaling suffers, often showing up as tingling, numbness, or discomfort. Nervora targets all three with its core nutrients.
Nerve cells are vulnerable to oxidative stress - damage from unstable molecules called free radicals. Alpha-lipoic acid (ALA) is a unique antioxidant that works in both water- and fat-based parts of the cell, neutralizing free radicals and even helping regenerate other antioxidants. It also supports healthy blood flow to nerves. ALA is the most-studied nutritional agent for nerve symptoms, with multiple randomized trials and meta-analyses (PMID 22439935, PMID 29408822).
Benfotiamine is a fat-soluble form of vitamin B1 (thiamine) that absorbs far better than the standard water-soluble form. Inside the body it supports the enzymes nerves use to produce energy, and it helps blunt the harmful glucose-driven pathways that stress nerves over time. Randomized research (the BENDIP study) found benfotiamine improved neuropathy scores (PMID 16940835), and it also supports healthy endothelial (blood vessel) function (PMID 20367783).
Vitamin B12 is essential for the myelin sheath - the protective insulation around nerve fibers that lets signals travel quickly and accurately. It is also needed for nerve cell maintenance and healthy signaling. B12 deficiency is a classic, well-documented cause of peripheral nerve problems, and correcting it is clearly beneficial (PMID 33530881, PMID 27086182). Combined with ALA, B12 has been studied for diabetic nerve symptoms (PMID 23664235).
| Ingredient | Primary Role | What It Supports |
|---|---|---|
| Alpha-Lipoic Acid | Antioxidant + circulation | Protects nerves from oxidative stress; blood flow |
| Benfotiamine (B1) | Nerve energy metabolism | Energy production; guards against glucose stress |
| Vitamin B12 | Myelin & signaling | Maintains nerve insulation and signal transmission |
No single nutrient covers every aspect of nerve health. Antioxidant protection without adequate B vitamins, or B vitamins without antioxidant support, each leaves a gap. By combining ALA, benfotiamine, and B12, Nervora aims to address protection, energy, and maintenance together - which is also why most clinical research on nerve nutrition uses combinations rather than single ingredients (PMID 33255240).
Nerve-support nutrients work gradually. Most users report noticing changes - reduced tingling, better comfort, steadier energy - within 3 to 6 weeks, with benefits building over 8 to 12 weeks of consistent daily use. This is not an overnight fix and it is not a treatment for diagnosed neuropathy. It is daily nutritional support designed to complement a healthy lifestyle - good nutrition, hydration, movement, and sleep - and regular medical care.
The research doses matter: ALA trials often use around 600 mg/day, and benfotiamine trials around 300 mg/day. Nervora does not publish its exact per-ingredient amounts publicly, so it is not possible to confirm how its doses compare to those used in studies. If precise dosing matters to you, request a Certificate of Analysis from the brand before buying. This is a transparency gap worth knowing - the ingredients are well-chosen, but the finished formula's specific doses are undisclosed.
Mijnhout GS, et al. (2012) "Alpha lipoic acid for symptomatic peripheral neuropathy in patients with diabetes: a meta-analysis of randomized controlled trials." Int J Endocrinol. PMID: 22439935
Stracke H, et al. (2008) "Benfotiamine in diabetic polyneuropathy (BENDIP): a randomised, double-blind, placebo-controlled study." Exp Clin Endocrinol Diabetes. PMID: 16940835
Baicus C, et al. (2021) "Vitamin B12 deficiency and peripheral neuropathy: a clinical review." Front Neurol. PMID: 33530881
Xu Q, et al. (2013) "Meta-analysis of methylcobalamin alone and in combination with lipoic acid in patients with diabetic peripheral neuropathy." Diabetes Res Clin Pract. PMID: 23664235
Stirban A, et al. (2006) "Benfotiamine prevents macro- and microvascular endothelial dysfunction." Diabetes Care. PMID: 20367783
Citations refer to research on the individual ingredients, not on the Nervora product itself. Many studies use doses, forms, or populations (often people with diabetic neuropathy) that may differ from general use. Nervora is a dietary supplement; these statements have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease.